Fed. Circ. In June: When Courts Can't Correct Patent Errors
This article is part of a monthly column that highlights an important recent patent appeal. In this installment, we examine the Federal Circuit's ruling in Enanta Pharmaceuticals Inc. v. Pfizer Inc....To view the full article, register now.
Already a subscriber? Click here to view full article